Fig. 2: Pathogenic pathways and the role of biomarkers in preeclampsia development.
From: Biomarkers and point of care screening approaches for the management of preeclampsia
Biomarkers in the starred categories have commercial devices, with violet indicating biomarkers cleared by the FDA and CE marked, and blue indicating CE marked biomarkers. Overall, the biomarkers in square categories fall under Level A, with green indicating Sub-Level II, and yellow indicating Sub-Level III classifications. The biomarkers in circle categories fall under Levels B (orange) and C (red) respectively. Details for each biomarker classification can be found in Supplementary Data 3. Created with BioRender.com
